Hints and tips:
Related Special Reports
...The University of Oxford spinout is pushing genetic testing beyond the search for individual genes, looking at how combinations of genes increase people’s likelihood of developing diseases such as cancer...
...The company crunches data from medical tests that have already been carried out to zero in on patterns that can predict cancers....
...Other investors in the company are Sanofi Ventures and the Cambridge university’s venture fund....
...The writer is a medical anthropologist, health psychologist and senior researcher at University College London Nearly everyone knows pain....
...The medical tourism component was “creative”, he added, emphasising that the key was to make “a live rhino worth more than a dead rhino”....
..., his Bordeaux University Hospital counterpart....
...It’s a drug that’s active against [resistant] pathogens that gives us a tool to treat the type of infection that we don’t have good options for now,” said Jay Purdy, Pfizer’s vice-president of global medical...
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
..., a chemical company based in Tokyo, launched an agricultural fungicide called ipflufenoquin in Japan in 2021, which has a mechanism of action very similar to F2G’s olorofim — leading to concerns among medical...
...and the UK’s Warwick university....
...The cresomycin test results looked “promising”, said Tim Walsh, an Oxford university professor and AMR expert....
...“What you want is that information flows as freely and as fast as possible, between universities and companies and researchers,” the official said....
...“The presence of interferon-γ could be used to diagnose long Covid in some patients,” said Benjamin Krishna, co-author of the paper and a Cambridge university researcher....
...The treatment proved simple, convenient and precisely targeted, said Padmalal Gurugama, co-author of the paper and a consultant in clinical immunology and allergy at Cambridge University Hospital....
...Overall, consultants McKinsey estimated in a report in January that AI could generate $60bn-$110bn a year for the pharmaceutical and medical-product industries by identifying compounds for possible new drugs...
...But according to a peer-reviewed study by Sweden’s Gothenburg university, a blood test known as the p-tau217 immunoassay yielded “high accuracy” in identifying tau, one of the proteins associated with a...
...While Elliott has a long record of distressed debt investing, it is best known in the UK for its activist equity bets, including pushing for change at pharmaceuticals group GSK and more recently at Scottish...
...Pharmaceuticals companies are using AI to identify new molecules as targets for possible anticancer drugs....
...Blight and Gomes worked together at Oxford university’s Jenner Institute. They founded Baseimmune with software engineer Phillip Kemlo in 2019....
...A second vaccination developed by scientists at Oxford university and produced by the Serum Institute of India is set to be delivered in seven countries in May or June....
...It’s tantamount to what the Nazis did,” said Francis Timmons, a councillor in south Dublin, referring to medical experiments in concentration camps during the second world war....
...Lobritz is co-author with experts from Harvard University of the two papers published in Nature on Wednesday....
...The project, led by government-owned Genomics England in collaboration with the NHS, universities and hospital trusts involved 13,880 volunteers....
...The Medical Research Council has filed a patent application based on the latest work....
...a Virginia Commonwealth University School of Medicine professor and principal investigator of the phase II trial....
International Edition